{"schema_version":"secwatch.filing_event.v1","accession":"0001770787-21-000048","form_type":"8-K","ticker":"TXG","cik":"0001770787","company_name":"10x Genomics, Inc.","filed_at":"2021-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.053999+00:00","generated_at":"2026-06-28T14:27:48.619904+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"10x Genomics Q3 revenue $125.3M (+74% YoY); FY2021 guidance raised to $490-500M","bullets":["Revenue $125.3M, up 74% YoY and 8% QoQ; operating loss $15.9M vs $65.3M loss last year.","Gross margin flat at 80%; net loss $17.2M vs $65.8M loss Q3 2020.","Cash $600.4M; began shipping Chromium X instrument.","FY2021 revenue guidance revised to $490-500M (64-67% growth over FY2020)."],"urls":{"canonical":"https://secwatch.observer/filing/0001770787-21-000048","json":"https://secwatch.observer/filing/0001770787-21-000048.json","markdown":"https://secwatch.observer/filing/0001770787-21-000048.md","text":"https://secwatch.observer/filing/0001770787-21-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770787/000177078721000048/0001770787-21-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770787/000177078721000048/txg-20211103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T14:27:48.619904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}